Global Rabies Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 90

Published Date: 18 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

According to our (Global Info Research) latest study, the global Rabies Vaccine market size was valued at USD 958 million in 2022 and is forecast to a readjusted size of USD 1246.1 million by 2029 with a CAGR of 3.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.

China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.

In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.

This report is a detailed and comprehensive analysis for global Rabies Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Rabies Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Rabies Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Rabies Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Rabies Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rabies Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rabies Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng and Prcmise, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Rabies Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Vero Cell Rabies Vaccine
    BHK
    Chick Embryo Cell Rabies Vaccine
    Others

Market segment by Application
    Pre-exposure Prophylaxis
    Post-exposure Prophylaxis

Major players covered
    GSK (Novartis)
    Sanofi-Pasteur
    Chengda
    Yisheng
    Prcmise
    VACN
    Changsheng
    BCHT
    Hissen

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rabies Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rabies Vaccine, with price, sales, revenue and global market share of Rabies Vaccine from 2018 to 2023.
Chapter 3, the Rabies Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rabies Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Rabies Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rabies Vaccine.
Chapter 14 and 15, to describe Rabies Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Rabies Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Rabies Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Vero Cell Rabies Vaccine
        1.3.3 BHK
        1.3.4 Chick Embryo Cell Rabies Vaccine
        1.3.5 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Rabies Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Pre-exposure Prophylaxis
        1.4.3 Post-exposure Prophylaxis
    1.5 Global Rabies Vaccine Market Size & Forecast
        1.5.1 Global Rabies Vaccine Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Rabies Vaccine Sales Quantity (2018-2029)
        1.5.3 Global Rabies Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 GSK (Novartis)
        2.1.1 GSK (Novartis) Details
        2.1.2 GSK (Novartis) Major Business
        2.1.3 GSK (Novartis) Rabies Vaccine Product and Services
        2.1.4 GSK (Novartis) Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 GSK (Novartis) Recent Developments/Updates
    2.2 Sanofi-Pasteur
        2.2.1 Sanofi-Pasteur Details
        2.2.2 Sanofi-Pasteur Major Business
        2.2.3 Sanofi-Pasteur Rabies Vaccine Product and Services
        2.2.4 Sanofi-Pasteur Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Sanofi-Pasteur Recent Developments/Updates
    2.3 Chengda
        2.3.1 Chengda Details
        2.3.2 Chengda Major Business
        2.3.3 Chengda Rabies Vaccine Product and Services
        2.3.4 Chengda Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Chengda Recent Developments/Updates
    2.4 Yisheng
        2.4.1 Yisheng Details
        2.4.2 Yisheng Major Business
        2.4.3 Yisheng Rabies Vaccine Product and Services
        2.4.4 Yisheng Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Yisheng Recent Developments/Updates
    2.5 Prcmise
        2.5.1 Prcmise Details
        2.5.2 Prcmise Major Business
        2.5.3 Prcmise Rabies Vaccine Product and Services
        2.5.4 Prcmise Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Prcmise Recent Developments/Updates
    2.6 VACN
        2.6.1 VACN Details
        2.6.2 VACN Major Business
        2.6.3 VACN Rabies Vaccine Product and Services
        2.6.4 VACN Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 VACN Recent Developments/Updates
    2.7 Changsheng
        2.7.1 Changsheng Details
        2.7.2 Changsheng Major Business
        2.7.3 Changsheng Rabies Vaccine Product and Services
        2.7.4 Changsheng Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Changsheng Recent Developments/Updates
    2.8 BCHT
        2.8.1 BCHT Details
        2.8.2 BCHT Major Business
        2.8.3 BCHT Rabies Vaccine Product and Services
        2.8.4 BCHT Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 BCHT Recent Developments/Updates
    2.9 Hissen
        2.9.1 Hissen Details
        2.9.2 Hissen Major Business
        2.9.3 Hissen Rabies Vaccine Product and Services
        2.9.4 Hissen Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Hissen Recent Developments/Updates

3 Competitive Environment: Rabies Vaccine by Manufacturer
    3.1 Global Rabies Vaccine Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Rabies Vaccine Revenue by Manufacturer (2018-2023)
    3.3 Global Rabies Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Rabies Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Rabies Vaccine Manufacturer Market Share in 2022
        3.4.2 Top 6 Rabies Vaccine Manufacturer Market Share in 2022
    3.5 Rabies Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Rabies Vaccine Market: Region Footprint
        3.5.2 Rabies Vaccine Market: Company Product Type Footprint
        3.5.3 Rabies Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Rabies Vaccine Market Size by Region
        4.1.1 Global Rabies Vaccine Sales Quantity by Region (2018-2029)
        4.1.2 Global Rabies Vaccine Consumption Value by Region (2018-2029)
        4.1.3 Global Rabies Vaccine Average Price by Region (2018-2029)
    4.2 North America Rabies Vaccine Consumption Value (2018-2029)
    4.3 Europe Rabies Vaccine Consumption Value (2018-2029)
    4.4 Asia-Pacific Rabies Vaccine Consumption Value (2018-2029)
    4.5 South America Rabies Vaccine Consumption Value (2018-2029)
    4.6 Middle East and Africa Rabies Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Rabies Vaccine Sales Quantity by Type (2018-2029)
    5.2 Global Rabies Vaccine Consumption Value by Type (2018-2029)
    5.3 Global Rabies Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Rabies Vaccine Sales Quantity by Application (2018-2029)
    6.2 Global Rabies Vaccine Consumption Value by Application (2018-2029)
    6.3 Global Rabies Vaccine Average Price by Application (2018-2029)

7 North America
    7.1 North America Rabies Vaccine Sales Quantity by Type (2018-2029)
    7.2 North America Rabies Vaccine Sales Quantity by Application (2018-2029)
    7.3 North America Rabies Vaccine Market Size by Country
        7.3.1 North America Rabies Vaccine Sales Quantity by Country (2018-2029)
        7.3.2 North America Rabies Vaccine Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Rabies Vaccine Sales Quantity by Type (2018-2029)
    8.2 Europe Rabies Vaccine Sales Quantity by Application (2018-2029)
    8.3 Europe Rabies Vaccine Market Size by Country
        8.3.1 Europe Rabies Vaccine Sales Quantity by Country (2018-2029)
        8.3.2 Europe Rabies Vaccine Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Rabies Vaccine Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Rabies Vaccine Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Rabies Vaccine Market Size by Region
        9.3.1 Asia-Pacific Rabies Vaccine Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Rabies Vaccine Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Rabies Vaccine Sales Quantity by Type (2018-2029)
    10.2 South America Rabies Vaccine Sales Quantity by Application (2018-2029)
    10.3 South America Rabies Vaccine Market Size by Country
        10.3.1 South America Rabies Vaccine Sales Quantity by Country (2018-2029)
        10.3.2 South America Rabies Vaccine Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Rabies Vaccine Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Rabies Vaccine Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Rabies Vaccine Market Size by Country
        11.3.1 Middle East & Africa Rabies Vaccine Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Rabies Vaccine Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Rabies Vaccine Market Drivers
    12.2 Rabies Vaccine Market Restraints
    12.3 Rabies Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Rabies Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Rabies Vaccine
    13.3 Rabies Vaccine Production Process
    13.4 Rabies Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Rabies Vaccine Typical Distributors
    14.3 Rabies Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Rabies Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Rabies Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. GSK (Novartis) Basic Information, Manufacturing Base and Competitors
    Table 4. GSK (Novartis) Major Business
    Table 5. GSK (Novartis) Rabies Vaccine Product and Services
    Table 6. GSK (Novartis) Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. GSK (Novartis) Recent Developments/Updates
    Table 8. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
    Table 9. Sanofi-Pasteur Major Business
    Table 10. Sanofi-Pasteur Rabies Vaccine Product and Services
    Table 11. Sanofi-Pasteur Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Sanofi-Pasteur Recent Developments/Updates
    Table 13. Chengda Basic Information, Manufacturing Base and Competitors
    Table 14. Chengda Major Business
    Table 15. Chengda Rabies Vaccine Product and Services
    Table 16. Chengda Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Chengda Recent Developments/Updates
    Table 18. Yisheng Basic Information, Manufacturing Base and Competitors
    Table 19. Yisheng Major Business
    Table 20. Yisheng Rabies Vaccine Product and Services
    Table 21. Yisheng Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Yisheng Recent Developments/Updates
    Table 23. Prcmise Basic Information, Manufacturing Base and Competitors
    Table 24. Prcmise Major Business
    Table 25. Prcmise Rabies Vaccine Product and Services
    Table 26. Prcmise Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Prcmise Recent Developments/Updates
    Table 28. VACN Basic Information, Manufacturing Base and Competitors
    Table 29. VACN Major Business
    Table 30. VACN Rabies Vaccine Product and Services
    Table 31. VACN Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. VACN Recent Developments/Updates
    Table 33. Changsheng Basic Information, Manufacturing Base and Competitors
    Table 34. Changsheng Major Business
    Table 35. Changsheng Rabies Vaccine Product and Services
    Table 36. Changsheng Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Changsheng Recent Developments/Updates
    Table 38. BCHT Basic Information, Manufacturing Base and Competitors
    Table 39. BCHT Major Business
    Table 40. BCHT Rabies Vaccine Product and Services
    Table 41. BCHT Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. BCHT Recent Developments/Updates
    Table 43. Hissen Basic Information, Manufacturing Base and Competitors
    Table 44. Hissen Major Business
    Table 45. Hissen Rabies Vaccine Product and Services
    Table 46. Hissen Rabies Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Hissen Recent Developments/Updates
    Table 48. Global Rabies Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 49. Global Rabies Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 50. Global Rabies Vaccine Average Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 51. Market Position of Manufacturers in Rabies Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 52. Head Office and Rabies Vaccine Production Site of Key Manufacturer
    Table 53. Rabies Vaccine Market: Company Product Type Footprint
    Table 54. Rabies Vaccine Market: Company Product Application Footprint
    Table 55. Rabies Vaccine New Market Entrants and Barriers to Market Entry
    Table 56. Rabies Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 57. Global Rabies Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 58. Global Rabies Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 59. Global Rabies Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 60. Global Rabies Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 61. Global Rabies Vaccine Average Price by Region (2018-2023) & (USD/Unit)
    Table 62. Global Rabies Vaccine Average Price by Region (2024-2029) & (USD/Unit)
    Table 63. Global Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 64. Global Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 65. Global Rabies Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 66. Global Rabies Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 67. Global Rabies Vaccine Average Price by Type (2018-2023) & (USD/Unit)
    Table 68. Global Rabies Vaccine Average Price by Type (2024-2029) & (USD/Unit)
    Table 69. Global Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 70. Global Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 71. Global Rabies Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 72. Global Rabies Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 73. Global Rabies Vaccine Average Price by Application (2018-2023) & (USD/Unit)
    Table 74. Global Rabies Vaccine Average Price by Application (2024-2029) & (USD/Unit)
    Table 75. North America Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 76. North America Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 77. North America Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 78. North America Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 79. North America Rabies Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 80. North America Rabies Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 81. North America Rabies Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 82. North America Rabies Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 83. Europe Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 84. Europe Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 85. Europe Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 86. Europe Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 87. Europe Rabies Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 88. Europe Rabies Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 89. Europe Rabies Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 90. Europe Rabies Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 91. Asia-Pacific Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 92. Asia-Pacific Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 93. Asia-Pacific Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 94. Asia-Pacific Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 95. Asia-Pacific Rabies Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 96. Asia-Pacific Rabies Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 97. Asia-Pacific Rabies Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 98. Asia-Pacific Rabies Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 99. South America Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 100. South America Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 101. South America Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 102. South America Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 103. South America Rabies Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 104. South America Rabies Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 105. South America Rabies Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 106. South America Rabies Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 107. Middle East & Africa Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 108. Middle East & Africa Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 109. Middle East & Africa Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 110. Middle East & Africa Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 111. Middle East & Africa Rabies Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 112. Middle East & Africa Rabies Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 113. Middle East & Africa Rabies Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 114. Middle East & Africa Rabies Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 115. Rabies Vaccine Raw Material
    Table 116. Key Manufacturers of Rabies Vaccine Raw Materials
    Table 117. Rabies Vaccine Typical Distributors
    Table 118. Rabies Vaccine Typical Customers
List of Figures
    Figure 1. Rabies Vaccine Picture
    Figure 2. Global Rabies Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Rabies Vaccine Consumption Value Market Share by Type in 2022
    Figure 4. Vero Cell Rabies Vaccine Examples
    Figure 5. BHK Examples
    Figure 6. Chick Embryo Cell Rabies Vaccine Examples
    Figure 7. Others Examples
    Figure 8. Global Rabies Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 9. Global Rabies Vaccine Consumption Value Market Share by Application in 2022
    Figure 10. Pre-exposure Prophylaxis Examples
    Figure 11. Post-exposure Prophylaxis Examples
    Figure 12. Global Rabies Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Rabies Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Rabies Vaccine Sales Quantity (2018-2029) & (K Units)
    Figure 15. Global Rabies Vaccine Average Price (2018-2029) & (USD/Unit)
    Figure 16. Global Rabies Vaccine Sales Quantity Market Share by Manufacturer in 2022
    Figure 17. Global Rabies Vaccine Consumption Value Market Share by Manufacturer in 2022
    Figure 18. Producer Shipments of Rabies Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 19. Top 3 Rabies Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Top 6 Rabies Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Global Rabies Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 22. Global Rabies Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 23. North America Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 24. Europe Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 25. Asia-Pacific Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 26. South America Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 27. Middle East & Africa Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 28. Global Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 29. Global Rabies Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 30. Global Rabies Vaccine Average Price by Type (2018-2029) & (USD/Unit)
    Figure 31. Global Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 32. Global Rabies Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 33. Global Rabies Vaccine Average Price by Application (2018-2029) & (USD/Unit)
    Figure 34. North America Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 35. North America Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 36. North America Rabies Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 37. North America Rabies Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 38. United States Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Canada Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Mexico Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Europe Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 42. Europe Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 43. Europe Rabies Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 44. Europe Rabies Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 45. Germany Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. France Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. United Kingdom Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Russia Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Italy Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Asia-Pacific Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 51. Asia-Pacific Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 52. Asia-Pacific Rabies Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 53. Asia-Pacific Rabies Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 54. China Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Japan Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Korea Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. India Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Southeast Asia Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Australia Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. South America Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 61. South America Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 62. South America Rabies Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 63. South America Rabies Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 64. Brazil Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Argentina Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Middle East & Africa Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 67. Middle East & Africa Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 68. Middle East & Africa Rabies Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 69. Middle East & Africa Rabies Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 70. Turkey Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Egypt Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Saudi Arabia Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. South Africa Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Rabies Vaccine Market Drivers
    Figure 75. Rabies Vaccine Market Restraints
    Figure 76. Rabies Vaccine Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Rabies Vaccine in 2022
    Figure 79. Manufacturing Process Analysis of Rabies Vaccine
    Figure 80. Rabies Vaccine Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Rabies Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Rabies Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Rabies Vaccine market size was valued at USD 958 million in 2023 and is forecast to a readjusted size of USD 1246.1 million by 2030 with a CAGR of 3.8% during review period.

Global Rabies Vaccine Supply, Demand and Key Producers, 2024-2030

Global Rabies Vaccine Supply, Demand and Key Producers, 2024-2030

date 09 Feb 2024

date Pharma & Healthcare

The global Rabies Vaccine market size is expected to reach $ 1246.1 million by 2030, rising at a market growth of 3.8% CAGR during the forecast period (2024-2030).

Global Rabies Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Global Rabies Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

date 13 Jan 2025

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Rabies Vaccine market size was valued at US$ 1036 million in 2024 and is forecast to a readjusted size of USD 1350 million by 2031 with a CAGR of 3.9% during review period.

Product Tags

Rabies Vaccine

Human Rabies Vaccine

Human Lyophilized Rabies Vaccine

Veterinary Rabies Vaccine

Animal Rabies Vaccine

Animal Anti Rabies Vaccine

Rabies Vaccine for Humans

Freeze-dried Human Rabies Vaccine

Human Rabies Vaccine (Vero Cell)

Human Diploid Cellular Rabies Vaccine

Rabies Vaccine for Pets

Human Diploid Cell Rabies Vaccine

Freeze-dried Human Rabies Vaccine (Vero Cells)

Oral Rabies Vaccine

Freeze-Dried Human Rabies Vaccine (Human Diploid Cells)

Pets Rabies Vaccine

Rabies Vaccine Antibody Testing Service

Pet Rabies Vaccine Antibody Testing Service

Human Rabies Vaccine Antibody Testing Service

Chick Embryo Cell Rabies Vaccine

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>